Table 2.
Anticoagulation indicators
| Group D | Group A | Group P | ||||
|---|---|---|---|---|---|---|
| 1 week | 2 week | 1 week | 2 week | 1 week | 2 week | |
| APTT (24–34 s) |
47.3 ± 9.7 | 50.1 ± 12.2 | 33.6 ± 4.9 | 31.8 ± 5.4 | 29.8 ± 2.3 | 30.0 ± 2.2 |
| PT (11–14 s) |
16.4 ± 1.9 | 16.3 ± 1.8 | 15.4 ± 2.6 | 15.0 ± 2.3 | 13.1 ± 0.5 | 13.0 ± 0.6 |
| F1 + 2 (69–229 pmol/l) |
150.4 ± 62.3 | 159.0 ± 62.1 | 130.9 ± 40.5 | 182.0 ± 116.6 | 230.7 ± 59.9 | 247.2 ± 76.9 |
| IL-6 (< 8 pg/ml) |
2.9 ± 4.2 | 2.3 ± 1.4 | 5.1 ± 4.8 | 3.1 ± 1.9 | 5.3 ± 6.7 | 2.4 ± 2.5 |
| hsCRP (< 0.30 mg/dl) |
0.10 ± 0.14 | 0.11 ± 0.13 | 0.22 ± 0.21 | 0.20 ± 0.19 | 0.19 ± 0.20 | 0.12 ± 0.16 |
| PTX3 (0.73–5.49 ng/ml) |
3.4 ± 3.8 | 2.9 ± 2.4 | 3.9 ± 2.8 | 3.5 ± 2.1 | 3.3 ± 2.5 | 3.0 ± 2.3 |
Normal range of each factor is indicated in parentheses. Data are presented as average ± standard deviation
APTT activated partial thromboplastin time, PT prothrombin time, F1 + 2 prothrombin fragment, IL-6 interleukin 6, hsCRP high sensitivity C-reactive protein, PTX3 pentraxin 3